Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals

Published:

|

Updated:

Changes

  • : Revised guidelines

Guidelines

The guidelines and associated template for submission must be used when preparing and submitting documentation for single technology assessments of medicinal products for decisions regarding public sector funding via the National Insurance scheme (“Blåresept”) and the Regional Health Authorities ("Nye metoder"). 


The guidelines were last revised in November 2023, see news post for details.
Submission Guidelines 


Documentation in compliance with the previous version of the guidelines will be accepted in a transition period of 6 months.

Contact us

Unit for HTA and general reimbursement

22 89 77 00

blaresept@noma.no

Unit for HTA hospital medicines

22 89 77 00

sykehus@noma.no